PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

T2 and collaborators announce discovery of novel clot structure biology enabled by T2HemoStat

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke and heart attack victims

2014-01-09
(Press-News.org) Contact information: Kari Watson
kwatson@macbiocom.com
781-235-3606
MacDougall Biomedical Communications, Inc.
T2 and collaborators announce discovery of novel clot structure biology enabled by T2HemoStat T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke and heart attack victims Lexington, MA, January 9, 2014 – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat™. T2HemoStat is an innovative diagnostic tool for assessing blood clotting, platelet function, fibrinolytic activity and hematocrit measurements from a fingerstick blood sample in about 15 minutes. T2HemoStat uniquely detects millions of data points during a blood coagulation cascade. Researchers at the University of Pennsylvania, utilizing T2HemoStat, detected a signature of a novel clot structure, never before described in scientific literature. This clot structure involves a conformational change in red blood cell structure, termed polyhedrocytes. The presence of these structures could make stroke and heart attack victims less responsive to medications. Blood clots are made up of fibrin, platelets and erythrocytes. Before now, little was known about the internal structure of contracted clots or the role that erythrocytes play in the contraction process. T2HemoStat is the first diagnostic method to enable the detection of this unique clot structure where erythrocytes are closely packed as polyhedra (polyhedrocytes) to form a seemingly impermeable barrier. This barrier means that these clot structures may be less susceptible to certain medications, called fibrinolytics, used to break up blood clots in the treatment of heart attacks and strokes. "Physicians treating the millions of patients at risk for thrombosis and bleeding, including after surgery or trauma, are in need of a more convenient method to provide up to the minute results of key hemostatic parameters," commented co-author Douglas B. Cines, MD, Professor of Pathology and Laboratory Medicine and Director of the Special Coagulation Laboratory, Perelman School of Medicine at the University of Pennsylvania. "Polyhedrocytes are likely to be central to preventing bleeding and promoting blood flow after damage to blood vessels has begun to heal. However, when the process goes awry, in the case of clotting diseases, these tightly packed erythrocytes present a challenge to clot-busting thrombolytic agents, as they are more resistant to fibrinolysis," said co-author John W. Weisel, Ph.D., Professor of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania. "This landmark publication demonstrates that T2HemoStat can be an important tool to identify biomarkers for companion diagnostics or new drug development, in this case, specifically targeted at highly contracted clots containing polyhedrocytes," added Tom Lowery, Ph.D., Chief Scientific Officer, T2 Biosystems and co-author in the study. "Furthermore, this new finding enabled by T2HemoStat demonstrates the power and versatility of our T2MR® technology both in the research setting and as it can relate to meaningful clinical advances." The paper, entitled "Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin", was authored by Douglas B. Cines, Tatiana Lebedeva, Chandrasekaran Nagaswami, Vincent Hayes, Walter Massefski, Rustem I. Litvinov, Lubica Rauova, Thomas J. Lowery and John W. Weisel. After identification of samples and sample conditions that form this novel clot with T2MR, the group used scanning electron and optical microscopy to determine that contracted clots consist of a meshwork of fibrin and platelet aggregates on the exterior of the clot with a closely-packed, tessellated array of compressed polyhedral erythrocytes (polyhedrocytes) on the interior. This phenomenon was observable both in vivo and in vitro in humans and mice, and is likely caused by the force that the fibrin and platelets place upon the erythrocytes, as centrifugation of erythrocytes in the absence of these components also generated the polyhedral structure. These results demonstrate how contracted clots form an impermeable barrier important for hemostasis and wound healing and help explain how fibrinolysis is greatly slowed as clots contract. ### About Hemostasis Hemostasis measurements aid healthcare professionals with critical therapeutic decision-making for patients undergoing surgery or trauma, as well as provide the ability to monitor prescription drug efficacy to avoid potential adverse events. Further, many of the impaired hemostasis conditions require advanced, novel diagnostic solutions to identify those diseases. These measurements currently require multiple test methods, and for measurements such as platelet activity, it can take hours to get a diagnostic result, which is not fast enough to treat those trauma, surgical, and other patients suspected of acute coagulopathy. By combining platelet function, clotting times, fibrinoloysis, along with many other measurements onto one instrument, the T2HemoStat™ system offers an unparalleled breadth of menu with all results available in about 15 minutes on fingerstick volumes of whole blood. The broad menu and rapid time to result will provide physicians with the data they need to make more informed treatment decisions that will result in better care for the patient and significant cost-savings. About T2 Biosystems T2 Biosystems is setting a new standard in clinical diagnostics powered by T2MR®, the world's first direct detection technology that delivers superior sensitivity at unmatched speed to guide more effective clinical decision-making. T2 Bio's pipeline of molecular diagnostic and hemostasis products is focused on conditions where rapid and accurate results will have the greatest impact on patients' lives and healthcare costs. The Company's lead products, T2Candida™ and T2Bacteria™, identify life-threatening pathogens associated with sepsis directly from whole blood up to 25-times faster than blood culture. Media Contact Kari Watson or Chris Erdman
MacDougall Biomedical Communications
781-235-3060
kwatson@macbiocom.com
cerdman@macbiocom.com


ELSE PRESS RELEASES FROM THIS DATE:

Stanford researcher's work provides glimpse into health of most-extreme runners

2014-01-09
Stanford researcher's work provides glimpse into health of most-extreme runners STANFORD, Calif. — For some runners, a marathon is not enough. Participation in so-called ultramarathons — defined as any distance beyond the standard 26.2-mile marathon ...

Study: 2-sizes-too-small 'Grinch' effect hampers heart transplantation success

2014-01-09
Study: 2-sizes-too-small 'Grinch' effect hampers heart transplantation success 22 years of data suggest need for new heart-size matching strategy to improve outcomes Baltimore, MD – January 8, 2014 – Current protocols for matching donor hearts to recipients ...

Epilepsy drug taken in pregnancy found safe in preschool child development

2014-01-09
Epilepsy drug taken in pregnancy found safe in preschool child development MINNEAPOLIS – A new study finds that the epilepsy drug levetiracetam appears not to be associated with thinking, movement and language problems for preschool children born to mothers who ...

2 million years ago, human relative 'Nutcracker Man' lived on tiger nuts

2014-01-09
2 million years ago, human relative 'Nutcracker Man' lived on tiger nuts An Oxford University study has concluded that our ancient ancestors who lived in East Africa between 2.4 million-1.4 million years ago mainly ate tiger nuts (grass bulbs) supplemented ...

Cardiologists urged to reduce inappropriate radiation exposure

2014-01-09
Cardiologists urged to reduce inappropriate radiation exposure Radiation from cardiology procedures equals more than 50 chest X-rays per person each year Sophia Antipolis, 9 January 2014: Cardiologists are being urged to reduce patient radiation exposure ...

New study finds upper-airway electronic stimulation effective for obstructive sleep apnea

2014-01-09
New study finds upper-airway electronic stimulation effective for obstructive sleep apnea UH Case Medical Center one of US and European clinical trial sites showing marked improvements for sleep apnea sufferers CLEVELAND: Results published ...

Study finds that information is as important as medication in reducing migraine pain

2014-01-09
Study finds that information is as important as medication in reducing migraine pain Findings also show that patients report pain relief even when they know they are receiving a placebo BOSTON – The information that clinicians provide to patients ...

Ancient Cambodian city's intensive land use led to extensive environmental impacts

2014-01-09
Ancient Cambodian city's intensive land use led to extensive environmental impacts Soil erosion may reveal ancient water management in Mahendraparvata Soil erosion and vegetation change indicate approximately 400 years of intensive land use around the city of Mahendraparvata ...

Neolithic mural may depict ancient eruption

2014-01-09
Neolithic mural may depict ancient eruption Volcanic rock age suggests Catalhoyuk mural may be based on Turkish eruption Volcanic rock dating suggests the painting of a Çatalhöyük mural may have overlapped with an eruption in Turkey according to results published ...

BOSS measures the universe to 1-percent accuracy

2014-01-09
BOSS measures the universe to 1-percent accuracy The Baryon Oscillation Spectroscopic Survey makes the most precise calibration yet of the universe's 'standard ruler' Today the Baryon Oscillation Spectroscopic Survey (BOSS) Collaboration announced that BOSS has ...

LAST 30 PRESS RELEASES:

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

[Press-News.org] T2 and collaborators announce discovery of novel clot structure biology enabled by T2HemoStat
T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke and heart attack victims